Cognition Therapeutics, Inc. stock forum
CGTX Positive results from the Phase 2 study on Lewy Body Dementia are in! 🚀 We're hopeful for FDA Fast Track approval to kick off Phase 3 soon. 🎯 Target prices are looking incredible: $1.50 to $22.00, with upgrades and fresh targets on the horizon. Did you know? Around 1.4 million people in the U.S. suffer from Lewy Body Dementia, costing $32 billion annually. Phase 3 is just around the corner in 2025, and with $29 million in cash and NIH funding, we’re good until 2026 to complete our studies. It's only a matter of time before things take off—2025 is going to be our year! 🌟CGTX I'm expecting the price to hit 2 today. My average cost per share is 0.83, and I hold 30,000 shares. I'm planning to sell 10,000 shares when the price reaches 1.7, and I'll keep the remaining 20,000 shares as a long-term investment since this stock looks very promising for the future.
CGTX we going to the moon with this one 🚀🚀🚀